NEW YORK (GenomeWeb News) – Biospecimen firm Sanguine BioSciences announced on Thursday the closing of its seed funding round.

The round was led by Invent Ventures and Heliant Ventures and will be used to further build Sanguine's infrastructure, it said. Sanguine did not disclose the amount of the funding.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.